Federal contract award
75N98026P01418
SPECIFIC ANTI-ALPHA-GAL IMMUNOCAPTM PHADIA CORE LABORATORY TESTING PHADIA US INC:1109918 [26-008249]
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH OLAO |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6640 — Laboratory Equipment and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $22.6K |
| Current contract value | $22.6K |
| Potential contract value / ceiling | $22.6K |
| Start date | Aug 31, 2026 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Aug 26, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 26, 2026 | 0 | $22.6K | SPECIFIC ANTI-ALPHA-GAL IMMUNOCAPTM PHADIA CORE LABORATORY TESTING PHADIA US INC:1109918 [26-008249] |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.